Download PDF
It has recently been reported that the co-Founder of London-based Google AI Lab, Mustafa Suleyman will be taking a leave of absence amid controversy surrounding the company.
 
Mr Suleyman has led the healthcare initiatives at DeepMind and has generally been known as the public face of the company since it was founded in 2010 alongside co-Founder  Demis Hassabis. In 2014, Google purchased the company for £400m.
 
A spokesperson for Mr Suleyman has not given a specific reason regarding his leave but the decision comes at an unstable time for the company amid complaints about its work with the NHS.
 
It was previously found that 1.6m patients’ information was shared with Royal Free Hospital, a partner of DeepMind. The companies were collaborating on a mobile app which would assist in the identification of patients at risk of Acute Kidney Injury (AKI). At the time of the incident, Mr Suleyman explained that the complications of sharing patient data were previously underestimated.
 
DeepMind has also run into some issues with its decision to move the company’s health division to Google, after previously stating this would not happen. Additionally, the 2018 financial records for DeepMind, released earlier this month, shows £1bn of debt. This reflects DeepMind’s efforts of hiring more AI experts to compete with Silicon Valley.
 
However, DeepMind’s breakthroughs continue as the company announced the success of its AKI prediction app in July.
 
Image Credit: DeepMind
 

«« Staff Training Urgently Needed for Healthcare Cybersecurity


Vendor-Driven Standards for Interoperability »»


AKI, acute kidney injury, Artificial Intelligence, mobile apps, NHS, AI, Google, London, DeepMind AI Lab Founder Goes on Leave, AI Lab, Google AI Lab, DeepMind, Mustafa Suleyman, Demis Hassabis, Suleyman, Royal Free Hospita

Latest Articles

  • Pharmacist in the ICU

    Pharmacists play a crucial role in the ICU, where patients often require complex medication regimens, including multiple medications and intravenous therapies. The role of a critical care pharmacist is multifaceted and vital to ensuring optimal patient care in the critical care setting.   Cr

    READ MORE
  • Defining Medicines Optimisation in the Intensive Care Unit

      Complex polypharmacy and pathophysiology are common in the intensive care unit (ICU). Medicines optimisation is essential to deliver safe, effective, and individualised pharmacotherapy. This is ideally performed by a specialised ICU pharmacist.   Introduction Medicines ar

    READ MORE
  • Critical Care Pharmacists Save Lives

      The purpose of this review is to discuss the role of critical care pharmacists on the interprofessional healthcare team in the care of critically ill patients and explore current gaps in the provision of comprehensive medication management.   Introduction   “The patient’s

    READ MORE
AKI, acute kidney injury, Artificial Intelligence, mobile apps, NHS, AI, Google, London, DeepMind AI Lab Founder Goes on Leave, AI Lab, Google AI Lab, DeepMind, Mustafa Suleyman, Demis Hassabis, Suleyman, Royal Free Hospita It has recently been reported that the co-Founder of London-based Google AI Lab, Mustafa Suleyman will be taking a leave of absence amid controversy surrounding the company.